Concomitant use not recommended due to serotonergic effects.
Source: NLP:venlafaxine hydrochloride
27 interactions on record
Concomitant use not recommended due to serotonergic effects.
Source: NLP:venlafaxine hydrochloride
Concomitant use increases risk of serotonin syndrome.
Source: NLP:citalopram
Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and dosage increases.
Source: NLP:citalopram hydrobromide
Serotonergic drug that increases risk of serotonin syndrome when combined with amphetamines. Initiate with lower doses and monitor for serotonin syndrome signs.
Source: NLP:dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
Serotonergic drug increasing risk of serotonin syndrome with dextroamphetamine sulfate.
Source: NLP:dextroamphetamine sulfate
Concomitant use with tryptophan is not recommended due to risk of serotonin syndrome.
Source: NLP:escitalopram
Concomitant use with tryptophan is not recommended due to risk of serotonin syndrome.
Source: NLP:escitalopram oxalate
Concomitant use with fluoxetine increases the risk of serotonin syndrome.
Source: NLP:fluoxetine
Concomitant use increases risk of serotonin syndrome; monitor for symptoms.
Source: NLP:fluoxetine hydrochloride
Severe vomiting with coadministration.
Source: NLP:fluvoxamine maleate
Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and dose increases.
Source: NLP:mirtazapine
Concomitant use increases risk of serotonin syndrome.
Source: NLP:paroxetine
Concomitant use may cause serotonin syndrome with adverse effects including headache, nausea, sweating, and dizziness. Concomitant use is not recommended.
Source: NLP:paroxetine hydrochloride hemihydrate
Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms, particularly during initiation and dosage increases.
Source: NLP:sertraline
Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms, particularly during treatment initiation and dosage increases.
Source: NLP:sertraline hydrochloride
Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms during trazodone initiation.
Source: NLP:trazodone hydrochloride
Risk of serotonin syndrome with concomitant therapy with tryptophan.
Source: NLP:ziprasidone
Risk of serotonin syndrome with concomitant serotonergic therapy including tryptophan.
Source: NLP:ziprasidone hydrochloride
Risk of serotonin syndrome with concomitant serotonergic therapy including tryptophan.
Source: NLP:ziprasidone mesylate
Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.
Source: NLP:desvenlafaxine
Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.
Source: NLP:desvenlafaxine er
Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.
Source: NLP:desvenlafaxine succinate
Serotonergic drug that increases risk of serotonin syndrome. Monitor for symptoms and discontinue if serotonin syndrome occurs.
Source: NLP:levomilnacipran hydrochloride
Concomitant use of serotonergic drugs with paroxetine increases the risk of serotonin syndrome. Monitor for symptoms.
Source: NLP:paroxetine hydrochloride
Concomitant use with tryptophan supplements not recommended due to serotonin syndrome risk.
Source: NLP:venlafaxine
Concomitant use not recommended due to serotonin syndrome risk.
Source: NLP:venlafaxine hydrochloride, extended release
Serotonergic drug that increases risk of serotonin syndrome; monitor patients for signs and symptoms during initiation.
Source: NLP:vilazodone hydrochloride